Research Institution Gap Funding and Accelerator Programs (GAP) Insights

GAP Insights | innovosource University innovation has made meaningful progress in developing Gap Fund and Accelerator Programs (GAP) that help research move toward commercialization. Pre-proof-of-concept initiatives, proof-of-concept funds, startup accelerators, and university venture funds have each become important components of the commercialization landscape. But an increasingly important question is emerging:

Award & Investment Overview University College London (UCL) has announced 26 awards through the first call of its Inspire Innovation Fund (Health), supporting early-stage translational research projects across therapeutics, diagnostics, medical devices, and digital health. Administered through the UCL Translational Research Office (TRO), the fund is designed to help university

Award & Investment Overview The Tulane Innovation Institute, in partnership with Provost Robin Forman, has awarded three Provost’s Proof of Concept (PPOC) Fund grants totaling $150,000 to university research teams developing technologies focused on the brain, nervous system, and neurological regulation of disease. Each project received $50,000 during the fund’s

Award & Investment Overview Estuary Biotherapeutics, a biotechnology company founded on research from Yale School of Medicine, has launched with $103 million in total committed financing to develop targeted gene therapies for serious kidney diseases. The financing includes a $93 million Series A led by RA Capital Management, following a

Award & Investment Overview OMass Therapeutics, a University of Oxford spinout developing small-molecule medicines for complex biological targets, has secured an oversubscribed $310 million (£230 million) Series C financing round. The round was co-led by Bain Capital Life Sciences, Forbion, and Novo Holdings, with additional participation from Janus Henderson Investors,

Award & Investment Overview Universal Quantum, a University of Sussex spinout developing modular quantum computing technology, has secured more than $100 million in Series A financing to accelerate commercialization, international expansion, and development of larger-scale quantum computing systems. The round was co-led by Firgun Ventures and DCVC, with participation from

Award & Investment Overview Colorado School of Mines has invested $1 million through Mines Venture Fund II in its first year, backing four university-aligned technology companies developing solutions in medical devices, sustainable construction materials, environmental technology, and assistive wearables. Each company received a $250,000 investment: Mines Venture Fund II plans

Award & Investment Overview MintNeuro, an Imperial College London spinout developing specialized semiconductor chips for neural devices, has raised $5 million from European and U.S. investors to move from technology validation into commercial scale-up. Odyssey Ventures led the round, with participation from 33East, JSK Investments, Alumni Ventures, Empirical Ventures, Jumpspace

Tulane University spinout Biophoundry has received a $250,000 investment from Tulane Ventures to advance its engineered phage therapy platform for antibiotic-resistant bacterial infections. The company was co-founded by Rani Brooks and Sahan Liyanagedera and is developing technology that could help address infections that no longer respond to conventional antibiotics. According